PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Ondansetron hydrochloride - Nausea and vomiting
PAD Profile : Ondansetron hydrochloride - Nausea and vomiting Important
Important Information :
Non-specific nausea / vomiting. See separate entries for pregnancy, post-operative and chemo-related indications.
Traffic Light Status
Status 1 of 2.
Status :
Red
Important
Formulations :
- Injection
- Oral solution
- Tablets
Important Information :
Off-label use. Only licensed for post-operative and chemotherapy-induced nausea and vomiting
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Status :
Red
Important
Formulations :
- Oro-dispersible
- Orodispersible films
Important Information :
Orodispersible preparations reserved for use when ordinary tablets are not suitable.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
- Domperidone
- Metoclopramide hydrochloride
- Cyclizine hydrochloride
- Promethazine hydrochloride
- Prochlorperazine maleate
Other Indications
- Nausea and vomiting (pregnancy)
- Nausea and vomiting (chemotherapy induced)
- Nausea and vomiting (post operative)
Additional Documents
No additional documents returned.
Committee Recommendations
No committee recommendations returned.
Associated BNF Codes
04. Central Nervous System
04.06.00. Drugs used in nausea and vertigo